Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Maintains Overweight on Adagene, Lowers Price Target to $7

Morgan Stanley Maintains Overweight on Adagene, Lowers Price Target to $7

Morgan Stanley analyst Matthew Harrison maintains Adagene (NASDAQ:ADAG) with a Overweight and lowers the price target from $15 to $7.

byBenzinga Newsdesk

September 9, 2022

1 minute read

Morgan Stanley analyst Matthew Harrison maintains Adagene (NASDAQ:ADAG) with a Overweight and lowers the price target from $15 to $7.

Figma Sets $12.5B Valuation in New Equity Offering, Falling Short of Adobe’s Acquisition Offer

By Anusuya Lahiri

May 17, 8:44 AM

Figma announces tender offer for investors to sell shares at $12.5B valuation, marking 25% increase from 2021. Deal falls short of Adobe's $20B offer.

ADBE

Movers
News

What’s Going On With Lucid Stock?

By Adam Eckert

February 1, 11:11 AM

Lucid Group Inc (NASDAQ:LCID) shares are trading higher Thursday, adding to gains of more than 30% over the last week. Here's a look at what's going on.

LCID